Industry Background:
Hemodialysis concentrates are intended for the hemodialysis treatment. It is mixed with purified water to generate a dialysate solution, employed during hemodialysis treatment. Dialysis fluid is prepared according to the individual patient’s needs to help regulate their electrolyte and acid-base balance and remove metabolic waste products. There are two types of hemodialysis concentrates are used such as Bicarbonate and acidic. They are available in powder and solution form. The increasing kidney-related disease across the globe driving the demand for the hemodialysis concentrates. In 2017, 746,557 Americans had kidney failure, and needed dialysis or a kidney transplant to survive. Nearly 500,000 of these patients received dialysis at least 3 times per week to replace kidney function. Nearly 125,000 people started ESKD treatment in 2017, of which 120,834 started dialysis, and 20,945 received a kidney transplant.
According to AMA Research, the market for Hemodialysis Concentrates is expected to register a CAGR of 5.73% during the forecast period to 2030. This growth is primarily driven by The Rising Kidney Related Diseases across the Globe
.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Forecast Period | 2024-2030 |
Volume Unit | K Tons |
Value Unit | USD (Million) |
Customization Scope | Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility |
The Health Care Supplies sector in the
region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Baxter International (United States), B. Braun (Germany), Rockwell Medical (United States), Fresenius Medical Care (Germany), Nipro (Japan), MEDIVATORS (United States), Dialysis Medical Solutions (United States), Unipharm JSC (United States), Renacon Pharma (Pakistan), Surni Group (India), Weigao Group (China), BIOLIGHT (China), Dialife SA (Switzerland) and Haemo Pharma GmbH (Austria), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
Key Developments in the Market:
In September 2021, Baxter International Inc. and NxStage Medical, Inc. announced a strategic partnership to develop and commercialize NxStage's innovative Sumo blood volume monitoring system for use in hemodialysis. The partnership will leverage Baxter's global reach and commercial expertise to bring Sumo to market in key regions around the world.
In October 2022, Fresenius Medical Care launched its new Estima hemodialysis system in the United States. Estima is a next-generation hemodialysis system that features a number of innovations designed to improve patient care and comfort, including a new dialysate delivery system, a new blood volume monitoring system, and a new user interface.The rising number of players expected to enter the global market is predicted to enhance the competition level as well as encourage the growth of the overall market shortly. Players are anticipated to focus on the development of new compounds, which is likely to encourage the growth of the global market throughout the forecast period.
Influencing Trend:
Rapid Technological Advancements in Hemodialysis Concentrates
Market Growth Drivers:
The Rising Kidney Related Diseases across the Globe, Negligible Preference of Patients for Kidney Transplantation, Increasing Prevalence of Diabetes and Hypertension and Increase in Investment for the Development of New Products and Reimbursement from Governments for the Treatment of Kidney Diseases
Challenges:
Sustainability of Small and Medium-Sized Companies in the Highly Competitive Market
Restraints:
Lower Awareness of Kidney Diseases Treatment Modalities and Stringent Regulatory Policies for the Approval and Manufacturing of Dialysis Products
Opportunities:
Increasing Number of Dialysis Centers and Growing Preference for Home Hemodialysis (HHD) Treatment
AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.
Data Sources of Hemodialysis Concentrates Market Study
Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Hemodialysis Concentrates Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.
The primary interviews and data collected as per the below protocols: By Designation: C-Level, D-Level, Others
By Company Type: Tier 1, Tier 2, Tier 3
Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Hemodialysis Concentrates players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.
Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
Against this Challenging Backdrop, Hemodialysis Concentrates Study Sheds Light on
The Hemodialysis Concentrates Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Hemodialysis Concentrates industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
Where Hemodialysis Concentrates industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.